K182698

Substantially Equivalent

LIAISON Calprotectin, LIAISON Calprotectin Control Set, LIAISON Calprotectin Calibration Verifiers, LIAISON Q.S.E.T. Buffer, LIAISON Q.S.E.T. Device

Applicant: DiaSorin, Inc.
Product code: NXO
Advisory panel: Immunology
Date received: 2018-09-27
Decision date: 2018-12-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Stillwater, MN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.